Related Experiment Videos
[Immunomodulating therapy in perforated peritonitis]
Khirurgiia
|May 1, 1991
Summary
Leukoconcentrate transfusions effectively boosted immune responses in generalized peritonitis patients post-surgery. This immunomodulating therapy, particularly 300-400 ml, showed the highest positive impact on immunological responsiveness.
Area of Science:
- Immunology
- Peritonitis Research
- Transfusion Medicine
Context:
- Generalized peritonitis presents significant postoperative immunological challenges.
- Assessing immune system recovery is crucial for patient outcomes.
- Immunomodulating therapies are explored to enhance recovery.
Purpose:
- To evaluate immunological responsiveness in patients with generalized peritonitis.
- To assess the efficacy of immunomodulating therapy in the postoperative period.
- To identify the most effective immunomodulating agent.
Summary:
- 160 patients with generalized peritonitis were studied for immunological responsiveness.
- 51 patients received immunomodulating therapy postoperatively.
- Transfusion of 300-400 ml leukoconcentrate demonstrated the most significant positive effect.
Impact:
- Highlights leukoconcentrate transfusion as a potent immunomodulatory strategy.
- Provides evidence for optimizing postoperative care in peritonitis patients.
- Informs clinical decisions regarding immune support in critical care settings.